What's new

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 3, Status: Authorised

Jun 24, 2025 - 13:50
 0
Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

EMEA-002021-PIP01-16-M01

Next Article

Human medicines European public assessment report (EPAR): Tolucombi, telmisartan...

Related Posts

EMEA-002042-PIP03-23

EMEA-002042-PIP03-23

Jun 6, 2025  0

Clinical Trials Information System (CTIS): Walk-in clinic - May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 May 2025, 16:00 (CEST) to 14 May 2025, 17:00 (CEST)

Clinical Trials Information System (CTIS): Walk-in clin...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

May 22, 2025  0